Today’s Medicare Payment Advisory Commission (MedPAC) vote to recommend changes to payments for drugs under Medicare Part B is a complete mistake. If implemented, the recommendations being forwarded to Congress will devastate our nation’s cancer care system. They will backfire if implemented and only worsen access-to-care problems while driving up cancer care costs.

Read the full Press Release here.